Diamedica Therapeutics Inc (DMAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,409 | 9,797 | 4,955 | 3,300 | 3,883 |
| Marketable Securities | 20,098 | 20,826 | 6,844 | 9,348 | 3,995 |
| Receivables | 340 | 335 | 319 | 985 | 823 |
| Other current assets | 10 | 10 | 46 | 195 | 88 |
| TOTAL | $27,921 | $31,106 | $12,399 | $14,165 | $8,836 |
| Non-Current Assets | |||||
| PPE Net | 74 | 50 | 55 | 60 | 64 |
| Other Non-Current Assets | 100 | 114 | 127 | 140 | 153 |
| TOTAL | $174 | $164 | $182 | $200 | $217 |
| Total Assets | $28,095 | $31,270 | $12,581 | $14,365 | $9,053 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,099 | 720 | 552 | 444 | 182 |
| Accrued Expenses | 864 | 658 | 609 | 435 | 1,076 |
| TOTAL | $2,028 | $1,443 | $1,217 | $935 | $1,318 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 46 | 61 | 82 | 96 | 105 |
| TOTAL | $53 | $69 | $92 | $107 | $118 |
| Total Liabilities | $2,081 | $1,512 | $1,309 | $1,042 | $1,436 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 18,776 | 18,739 | 18,739 | 14,139 | 14,139 |
| Retained earnings | -68,909 | -64,709 | -61,516 | -59,042 | -56,617 |
| Other shareholders' equity | -2 | 10 | 29 | 42 | 2 |
| TOTAL | $26,014 | $29,758 | $11,272 | $13,323 | $7,617 |
| Total Liabilities And Equity | $28,095 | $31,270 | $12,581 | $14,365 | $9,053 |